3SBio will seek to raise up to $712 million in its Hong Kong IPO, valuing the company at $2.9 billion; Youbo Pharma was acquired by Jiuzhitang Co., both TCM companies, in a reverse takeover for $1 billion of Jiuzhitang's stock; SciClone Pharma in-licensed greater China rights to Theravance's drug-resistant antibiotic in a $6 million deal; the CFDA sharply raised its review fees for drugs and medical devices, perhaps to hire more reviewers; Cellular Biomedicine, a China-California cell therapy company, reported positive data from a small trial of its Chimeric Antigen Receptor (CAR-T) immunotherapy for lymphoma; and Quintiles opened a new Greater China Regional Headquarters in Shanghai.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
